Xenobiotic Pregnane X Receptor (PXR) Regulates Innate Immunity via Activation of NLRP3 Inflammasome in Vascular Endothelial Cells*

Background: Xenobiotics activate nuclear receptor PXR for detoxification and clearance. However, a role of PXR in regulating innate immunity remains unknown. Results: PXR induced NLRP3 expression and triggered inflammasome activation in vascular ECs. Conclusion: PXR plays an important role in the activation of NLRP3 inflammasome in response to xenobiotics. Significance: Our findings revealed a novel mechanism of innate immunity. Pregnane X receptor (PXR) is a member of nuclear receptor superfamily and responsible for the detoxification of xenobiotics. Our previously study demonstrated that PXR is expressed in endothelial cells (ECs) and acts as a master regulator of detoxification genes to protect ECs against xenobiotics. Vascular endothelial cells are key sentinel cells to sense the pathogens and xenobiotics. In this study, we examined the potential function of PXR in the regulation of innate immunity in vasculatures. Treatments with PXR agonists or overexpression of a constitutively active PXR in cultured ECs increased gene expression of the key pattern recognition receptors, including Toll-like receptors (TLR-2, -4, -9) and NOD-like receptors (NOD-1 and -2 and NLRP3). In particular, PXR agonism triggered the activation of NLRP3 inflammasome and the ensuing cleavage and maturation of caspase-1 and interleukin-1β (IL-1β). Conversely, selective antagonism or gene silencing of PXR abrogated NLRP3 inflammasome activation. In addition, we identified NLRP3 as a transcriptional target of PXR by using the promoter-reporter and ChIP assays. In summary, our findings revealed a novel regulatory mechanism of innate immune by PXR, which may act as a master transcription factor controlling the convergence between the detoxification of xenobiotics and the innate immunity against them.

[1]  K. Boini,et al.  Endothelial NLRP3 inflammasome activation and enhanced neointima formation in mice by adipokine visfatin. , 2014, The American journal of pathology.

[2]  Lei Xiao,et al.  New paradigms in inflammatory signaling in vascular endothelial cells. , 2014, American journal of physiology. Heart and circulatory physiology.

[3]  A. Marneros,et al.  NLRP3 inflammasome blockade inhibits VEGF-A-induced age-related macular degeneration. , 2013, Cell reports.

[4]  Hong Wang,et al.  An evolving new paradigm: endothelial cells – conditional innate immune cells , 2013, Journal of Hematology & Oncology.

[5]  Y. Li,et al.  Shear stress activation of nuclear receptor PXR in endothelial detoxification , 2013, Proceedings of the National Academy of Sciences.

[6]  Traci L. Marin,et al.  Sterol Regulatory Element Binding Protein 2 Activation of NLRP3 Inflammasome in Endothelium Mediates Hemodynamic-Induced Atherosclerosis Susceptibility , 2013, Circulation.

[7]  E. Lien,et al.  Inflammasomes and host defenses against bacterial infections. , 2013, Current opinion in microbiology.

[8]  W. Xie,et al.  Targeting xenobiotic receptors PXR and CAR for metabolic diseases. , 2012, Trends in pharmacological sciences.

[9]  A. Cunha Innate immunity: Pathogen and xenobiotic sensing — back to basics , 2012, Nature Reviews Immunology.

[10]  G. Ruvkun,et al.  Inactivation of Conserved C. elegans Genes Engages Pathogen- and Xenobiotic-Associated Defenses , 2012, Cell.

[11]  J. Hollyfield,et al.  NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components , 2012, Nature Medicine.

[12]  Jianni Qi,et al.  TLR‐induced NF‐κB activation regulates NLRP3 expression in murine macrophages , 2012, FEBS letters.

[13]  Richard A. Flavell,et al.  Inflammasomes in health and disease , 2012, Nature.

[14]  T. Warner,et al.  Pregnane X receptor regulates drug metabolism and transport in the vasculature and protects from oxidative stress , 2011, Cardiovascular research.

[15]  J. Tschopp,et al.  The Inflammasomes , 2010, Cell.

[16]  N. Suttorp,et al.  Role of Toll-like receptors, NOD-like receptors and RIG-I-like receptors in endothelial cells and systemic infections , 2009, Thrombosis and Haemostasis.

[17]  Y. Yin,et al.  Inflammasomes are Differentially Expressed in Cardiovascular and other Tissues , 2009, International journal of immunopathology and pharmacology.

[18]  X. Chu,et al.  Identification of pregnane-X receptor target genes and coactivator and corepressor binding to promoter elements in human hepatocytes , 2009, Nucleic acids research.

[19]  J. Mueller,et al.  Initial description of the human NLRP3 promoter , 2008, Genes and Immunity.

[20]  B. Ryffel,et al.  Role of pattern-recognition receptors in cardiovascular health and disease. , 2007, Biochemical Society transactions.

[21]  F. Sutterwala,et al.  The Inflammasome: First Line of the Immune Response to Cell Stress , 2006, Cell.

[22]  B. Blumberg,et al.  Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation. , 2006, The Journal of clinical investigation.

[23]  S. Hood,et al.  Lignans, bacteriocides and organochlorine compounds activate the human pregnane X receptor (PXR). , 2005, Toxicology and applied pharmacology.

[24]  R. Hayward Stress , 2005, The Lancet.

[25]  R. Evans,et al.  A nuclear receptor-mediated xenobiotic response and its implication in drug metabolism and host protection. , 2003, Current drug metabolism.

[26]  T. Willson,et al.  Pxr, car and drug metabolism , 2002, Nature Reviews Drug Discovery.

[27]  E. Schuetz,et al.  Environmental xenobiotics and the antihormones cyproterone acetate and spironolactone use the nuclear hormone pregnenolone X receptor to activate the CYP3A23 hormone response element. , 1998, Molecular pharmacology.